|
Volumn 10, Issue 2, 2012, Pages 237-240
|
Comparison of myocardial and hepatic iron loading, assessed by MRI T2*, in patients with myelodysplastic syndromes, thalassaemia major and controls
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFEROXAMINE;
FERRITIN;
ADULT;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ASYMPTOMATIC DISEASE;
BACKACHE;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
CARDIAC PATIENT;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
CORRELATION COEFFICIENT;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FERRITIN BLOOD LEVEL;
HEART FUNCTION;
HEART HEMOSIDEROSIS;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART OUTPUT;
HUMAN;
IRON CHELATION;
IRON OVERLOAD;
LETTER;
LIVER HEMOSIDEROSIS;
LIVER TOXICITY;
LONG TERM CARE;
MALE;
MORBIDITY;
MORTALITY;
MYELODYSPLASTIC SYNDROME;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PROGNOSIS;
PULSE RATE;
SICKLE CELL ANEMIA;
SIDEROBLASTIC ANEMIA;
STATISTICAL SIGNIFICANCE;
STUDENT T TEST;
THALASSEMIA MAJOR;
TREATMENT DURATION;
ADULT;
BETA-THALASSEMIA;
BLOOD TRANSFUSION;
FEMALE;
HUMANS;
IRON;
LIVER;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MYELODYSPLASTIC SYNDROMES;
MYOCARDIUM;
|
EID: 84860542768
PISSN: 17232007
EISSN: None
Source Type: Journal
DOI: 10.2450/2011.0084-11 Document Type: Letter |
Times cited : (4)
|
References (5)
|